Fauci Says Data Shows Gilead's (GILD) Remdesivir has Clear Cut Positive Effect on Virus - Bloomberg
(Updated - April 29, 2020 12:00 PM EDT)
(Updated - April 29, 2020 11:59 AM EDT)
NIAID Director Anthony Fauci said the Gilead Sciences (NASDAQ: GILD) study in COVID-19 was quite good news, and remdesivir shows a clear cut positive effect on the virus and significant positive effect in diminishing recovery time, according to Bloomberg.